This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Steve Jobs Hits the Silver Screen in April

Stocks in this article: AAPL

NEW YORK ( TheStreet) -- Now that Ashton Kutcher is in full swing to play Apple (AAPL - Get Report) co-founder Steve Jobs in a movie about his life, moviegoers can start to get amped up for it, as the film has an April release date.

The film, jOBS, stars Kutcher, from Two and a Half Men and That 70s Show, in the earlier years of Jobs' life, profiling the most important 30 years of his career. It starts with the creation of Apple in the mid 1970s and runs all the way to his return to Apple after having been ousted from the company he started with Steve Wozniak. The Hollywood Reporter first reported the news.

The movie is slated to premiere at the Sundance Film Festival on Jan. 27.

In addition to having Kutcher play the lead role, there are a slew of Hollywood stars attached to the film. Matthew Modine will play former Apple CEO John Scully, J.K. Simmons will play Arthur Rock, and Josh Gad will play Wozniak.

There is another, more grandiose film being made about Jobs' life by Sony (SNE), which acquired the rights to the biography Steve Jobs, written by Walter Isaacson. The movie, Steve Jobs, will have Aaron Sorkin penning the script. No lead actor has yet been cast to play the role of the iconic tech guru.

-- Written by Chris Ciaccia in New York

>Contact by Email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs